skip to main content

Stephanie Anderson

Direct: 416.863.3351
Fax: 416.863.9171

Stephanie Anderson is a Partner at Belmore Neidrauer LLP. She was called to both the Ontario and New York State Bars in 2012. Stephanie’s practice is focused primarily on patent litigation including matters relating to the Food and Drug Regulations and product launches.

Stephanie earned her J.D. from Osgoode Hall Law School in 2011. During her time at Osgoode, she was a senior editor of the Osgoode Hall Law Journal and was a member of the Copenhagen Negotiation Competition Team on Access to Medicines. Stephanie also participated in an exchange program at the University of Amsterdam, where she interned at the International Criminal Tribunal for the former Yugoslavia (ICTY) in The Hague.

Prior to attending law school, Stephanie attended Trinity University in San Antonio, TX. She earned a B.Sc. degree in biology (minor in psychology) and played NCAA basketball. She completed an honours thesis in molecular evolution and published her research in the Journal of Heredity.


  • Called to the Ontario Bar, 2012
  • Called to the New York State Bar, 2012
  • Osgoode Hall Law School, J.D., 2011
  • Trinity University, B.Sc. (Biology) with Honours, 2008


  • Leading Life Sciences Lawyer in LMG’s Life Science’s 2022/23 edition
  • IAM 1000:  The World’s Leading Patent Professionals 2022:  Litigation
  • Managing Intellectual Property IP Star 2022
  • IP Stars 2020: Rising Star 2020/21
  • LMG Life Sciences Canadian Rising Star 2019 


Date Title Type


Date Case Title Expertise
Jul 28, 2021 2021 FCA 154 Seedlings v. Pfizer
We successfully represented Pfizer on this appeal related to a mechanical device patent and Pfizer’s epinephrine auto injector product EpiPen...


Mar 04, 2021 2021 FCA 45 Apotex v. Janssen
We successfully represented Janssen on this appeal. The Federal Court of Appeal upheld the trial judge’s decision that the patent was valid a...


Jan 14, 2021 2021 FC 7 Janssen v Apotex, Pharmascience and Dr. Reddy’s Laboratories
We represented Janssen and BTG in these patent infringement actions relating to Janssen’s prostate cancer product ZYTIGA®(abiraterone ace...


Jan 02, 2020 2020 FC 1 Seedlings Life Sciences v Pfizer
We successfully represented Pfizer in this patent infringement action. Seedlings – a non-practicing entity – alleged that Pfizer’...


Oct 29, 2019 2019 FC 1355 Janssen Inc. et al v Apotex Inc.
We successfully represented Janssen and BTG in this PMNOC application, the last of such proceedings to be heard under the “old” applica...


More Cases


  • Intellectual Property Institute of Canada (IPIC)
  • Canadian Bar Association
  • Osgoode Hall Law School Student Mentor

Stephanie Anderson 


Direct: 416.863.3351
Fax: 416.863.9171

Christina Duarte
Direct: 416.863.3362T 416.863.3362

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy